BioMark Diagnostics, Inc. (BUX.CX)
0.475
0.00 (0.00%)
CAD |
CNSX |
Dec 05, 16:00
BioMark Diagnostics EPS Diluted (Quarterly): -0.0046 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Justera Health Ltd. | -0.0022 |
| Neural Therapeutics, Inc. | -- |
| ARCpoint, Inc. | -0.0056 |
| Biocure Technology, Inc. | -0.0029 |
| Core One Labs, Inc. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.4814M |
| Revenue (Quarterly) | 0.0069M |
| Total Expenses (Quarterly) | 0.4883M |
| Enterprise Value | 48.53M |
| Gross Profit Margin (Quarterly) | -1.15K% |
| Profit Margin (Quarterly) | -6.98K% |
| Earnings Yield | -3.43% |
| Normalized Earnings Yield | -3.663 |